[Federal Register Volume 86, Number 135 (Monday, July 19, 2021)]
[Notices]
[Pages 38096-38097]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-15226]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30Day-21-21DC]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled National Syringe Services Program (SSP) 
Evaluation to the Office of Management and Budget (OMB) for review and 
approval. CDC previously published a ``Proposed Data Collection 
Submitted for Public Comment and Recommendations'' notice on February 
25, 2021 to obtain comments from the public and affected agencies. CDC 
received three public comments related to the previous notice. This 
notice serves to allow an additional 30 days for public and affected 
agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570. Comments and recommendations for the proposed 
information collection should be sent within 30 days of publication of 
this notice to www.reginfo.gov/public/do/PRAMain. Find this particular 
information collection by selecting ``Currently under 30-day Review--
Open

[[Page 38097]]

for Public Comments'' or by using the search function. Direct written 
comments and/or suggestions regarding the items contained in this 
notice to the Attention: CDC Desk Officer, Office of Management and 
Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202) 
395-5806. Provide written comments within 30 days of notice 
publication.

Proposed Project

    National Syringe Services Program Evaluation--New--National Center 
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention (NCHHSTP), 
Centers for Disease Control and Prevention (CDC).

Background and Brief Description

    The primary purpose of the National Syringe Services Program (SSP) 
Evaluation is to strengthen and improve the capacity of SSPs to conduct 
regular monitoring and evaluation to ensure that comprehensive 
prevention services are provided to meet the needs of people who inject 
drugs (PWID). The project will include SSPs that are listed in a 
publicly available directory of all known SSPs in the United States 
maintained by the North American Syringe Exchange Network (NASEN; 
https://nasen.org). SSPs will be sent a letter of invitation to 
participate in a 35-minute program survey, called the Dave Purchase 
Memorial Survey. Participating programs will have the option of 
completing the survey via different modalities to enhance feasibility 
and comfort in completing the survey, for example via the Research 
Electronic Data Capture (REDCap) or a similarly secure web-based 
application. Other modalities for survey administration will include a 
coordinated telephone or videoconferencing interview.
    The survey will include questions on operational characteristics 
and services, client characteristics and drug use patterns, client 
satisfaction, funding resources, community relations, and key 
operational successes and challenges. Approximately 600 SSPs will be 
able to participate in the survey. We anticipate that approximately 20% 
of SSPs will decline to complete the survey, yielding approximately 480 
completed surveys per year. However, given that this is the first 
survey of SSPs funded by CDC during the COVID-19 pandemic, it makes it 
challenging to predict response rates. We estimate that it will take 35 
minutes to complete the survey, regardless of how the respondent 
chooses to complete it (i.e., self-administered online or interviewer-
administered by phone or videoconferencing). SSPs that do not respond 
to the initial survey invitation will be given reminders to complete 
the survey over the duration of the survey implementation period. The 
final reminder will include a link to a single question for SSPs that 
choose not to complete the survey about why they declined to complete 
the survey. Given the uncertainties in response rates described above, 
we are requesting enough burden hours to allow at least 80% of SSPs to 
respond to this question. We estimate that it will take two minutes to 
respond to this question.
    The total estimated annual burden hours are 296. There are no other 
costs to respondents other than their time.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
          Type of respondents                   Form name            Number of    responses  per   per  response
                                                                    respondents      respondent       (hours)
----------------------------------------------------------------------------------------------------------------
All participating SSPs................  Survey Y1 and Survey Y2-             480               1           35/60
                                         3.
Non-responding SSPs...................  Non-Response Survey Item             480               1            2/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention.
[FR Doc. 2021-15226 Filed 7-16-21; 8:45 am]
BILLING CODE 4163-18-P